Breathing Support After Breathing Tube Removal in Severely Obese Patients
Tests noninvasive breathing support after tube removal in adults with severe obesity.
Key facts
- Who runs it
- Rush University Medical Center
- Where
- Chicago, Houston, Milwaukee, and Winfield, United StatesSee the 4 sitesAlso in 1 other country, 1 site
- Trial code
- Registry title
- Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 10 Jul 2023
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Noninvasive ventilation alternating with high flow nasal cannula
- High flow nasal cannula
- Record updated
- 7 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe obesity who have been on a breathing machine for at least 24 hours and are about to have the breathing tube removed.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Severe obesity (BMI 40 kg/m2 or higher) and on a breathing machine for 24 hours or more, with a planned removal of the breathing tube.
- Earlier treatment
- Must have had invasive mechanical ventilation for 24 hours or more.
- Biomarker or test result
- Blood pH of 7.35 or higher (arterial) or 7.31 or higher (venous) within 30 minutes of the spontaneous breathing trial (SBT).
Main reasons for not taking part
- Pregnant
- Using extra-corporeal membrane oxygenation
- Has a chronic tracheostomy
- Breathing tube removed by accident or unplanned, or as end-of-life care
- Intubated because of an acute flare-up of COPD, or has a neuromuscular disease
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Adult, age ≥ 18 years old
- Receiving invasive mechanical ventilation for ≥24 hours
- BMI ≥40 kg/m2
- Undergoing planned extubation per treating team
- Arterial pH ≥7.35 or venous pH ≥ 7.31 within 30 mins of spontaneous breathing trial (SBT)
Who cannot take part
- Underlying neuromuscular disease
- Documented/known history of chronic hypercapnic respiratory failure on home NIV (including bilevel PAP)
- Pregnant
- Use of extra-corporeal membrane oxygenation
- Chronic tracheostomy in place
- Unplanned or accidental extubation
- Terminal/compassionate extubation
- Contraindication to NIV use
- Intubated because of an acute exacerbation of COPD
- No reintubation requested by patient/family
- Enrolled in any other outcome study
- Treating clinician feels that HFNC or NIV are either mandatory or contraindicated for a given patient
Where in United States
Also in 1 other country, 1 site
- Rush University Medical CenterChicago, United StatesContact: Ramandeep Kaur, PhDTaking people
- McGovern Medical School, The University of Texas Health Science CenterHouston, United StatesContact: Rosa M. Estrada-Y-Martin, MDTaking people
- Medical College of WisconsinMilwaukee, United StatesContact: Rahul Nanchal, MDTaking people
- Central DuPage HospitalWinfield, United StatesContact: Ankeet PatelNot yet recruiting
About the trial
What the trial wants to find out
Around 20% of the obese patients with higher body mass index (BMI) who are taken off the breathing tube and breathing machine (ventilator) end up needing it back to support breathing. The re-application of breathing tube is associated with poor outcomes, including high risk of pneumonia, longer hospital stays, and death. The purpose of this study is to assess if prophylactic use of noninvasive breathing support after removing the breathing tube lowers the chance of needing the breathing tube again.
The 2 groups in the trial
- Intervention Group (NIV with HFNC)Treatment being tested
Patients randomized to the intervention group will receive NIV alternating with HFNC for 24 hours after extubation
Treatment: Noninvasive ventilation alternating with high flow nasal cannula
- Control Group (HFNC alone)Existing treatment, for comparison
Patients randomized to the intervention group will receive HFNC only for 24 hours after extubation
Treatment: High flow nasal cannula
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Randomized Controlled Trial of Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
- Plain-language title
- Breathing Support After Breathing Tube Removal in Severely Obese PatientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 7 August 2026